News
PYPD
4.720
+6.79%
0.300
Roth MKM Remains a Buy on PolyPid (PYPD)
TipRanks · 1d ago
PolyPid To Present New Phase 3 SHIELD II Data On D-PLEX100 At ESCMID 2026
NASDAQ · 1d ago
PolyPid To Present Phase 3 SHIELD II Data Showing Sustained Local Doxycycline Release And Minimal Systemic Exposure At ESCMID 2026 Conference
Benzinga · 2d ago
PolyPid says SHIELD II data show D-PLEX100 doxycycline release lasts up to 32 days
PUBT · 2d ago
Weekly Report: what happened at PYPD last week (0406-0410)?
Weekly Report · 2d ago
PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026
Barchart · 2d ago
PolyPid starts trading on Frankfurt Stock Exchange under 2PV, adding to Nasdaq listing
Reuters · 04/08 15:45
PolyPid director Yitzhak Jacobovitz files initial beneficial ownership statement
Reuters · 04/06 20:02
PolyPid files Form 3 disclosing director Robert Benjamin Stein holdings
Reuters · 04/06 12:02
Weekly Report: what happened at PYPD last week (0330-0403)?
Weekly Report · 04/06 09:59
PolyPid initiates rolling FDA NDA submission for D-PLEX100 in colorectal surgery SSIs
Reuters · 03/31 21:31
PolyPid Begins FDA NDA Submission for D-PLEX₁₀₀ to Prevent Surgical Infections
TipRanks · 03/31 18:16
PolyPid’s Moment Is Here: NDA Submission Begins as a High-Impact Catalyst Stack Takes Shape (NASDAQ: PYPD)
TipRanks · 03/31 14:30
BRIEF-Polypid Initiates D-Plex₁₀₀ NDA Submission To The FDA
Reuters · 03/31 12:43
Weekly Report: what happened at PYPD last week (0323-0327)?
Weekly Report · 03/30 10:00
PolyPid files initial beneficial ownership statement; COO-US Ori Warshavsky reports 267 ordinary shares owned directly
Reuters · 03/26 20:01
PolyPid files initial beneficial ownership statement; director Nir Dror-Darwish reports 14,440 stock options at $2.67
Reuters · 03/26 12:56
PolyPid Ltd. CFO Jonathan Missulawin files initial beneficial ownership statement
Reuters · 03/23 20:01
PolyPid Director Joseph BenAmram Files Initial Beneficial Ownership Statement
Reuters · 03/23 12:04
Weekly Report: what happened at PYPD last week (0316-0320)?
Weekly Report · 03/23 09:56
More
Webull provides a variety of real-time PYPD stock news. You can receive the latest news about Polypid Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.